Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: Outcomes of living donor liver transplantations

Internal Medicine

Volumn 44, Issue 11, 2005, Pages 1151-1156

  Takei, Yo Ichi ^a   Ikeda, Shu Ichi ^a   Ikegami, Toshihiko ^a   Hashikura, Yasuhiko ^a   Miyagawa, Shin Ichi ^a   Ando, Yukio ^b   Furukawa, Hiroyuki ^c   Shimazu, Motohide ^d   Kitajima, Masaki ^d   Kamei, Hideya ^e   Maehara, Yoshihiko ^f   Nakao, Rie ^f   Hatakeyama, Katsuyoshi ^g   Makuuchi, Masatoshi ^h   Matsui, Yuichi ^h   Umeshita, Koji ⁱ  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d KEIO UNIVERSITY HOSPITAL   (Japan)

^e NAGOYA UNIVERSITY HOSPITAL   (Japan)

^f KYUSHU UNIVERSITY HOSPITAL   (Japan)

^g NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^h UNIVERSITY OF TOKYO HOSPITAL   (Japan)

ⁱ OSAKA UNIVERSITY   (Japan)

Author keywords

Familial amyloid polyneuropathy; Japan; Living donor liver transplantation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CADAVER DONOR; CORRELATION ANALYSIS; DISEASE SEVERITY; EXPERIENCE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GRAFT RECIPIENT; HUMAN; INFORMATION PROCESSING; JAPAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NUTRITIONAL STATUS; ORTHOTOPIC TRANSPLANTATION; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SURVIVAL RATE; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644846159     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.1151     Document Type: Article

References (36)

1. Ikeda S, Hanyu N, Hongo M, et al. Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 110: 315-337, 1987.
2. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75: 408-427, 1952.
3. Andersson R. Hereditary amyloidosis with polyneuropathy. Acta Med Scand 2: 85-94, 1970.
4. Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci 75: 4499-4503, 1978.
5. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 10: 160-184, 2003.
6. Holmgren G, Steen L, Ekstedt J, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 40: 242-246, 1991.
7. Ericzon BG, Larsson M, Herlenius G, Wilczek HE on behalf of reporting members of the FAPWTR: Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR). Amyloid 10: Suppl 1: 67-76, 2003.
8. Furtado A, Tome L, Oliveira FJ, Furtado E, Viana J, Perdigoto R. Sequential liver transplantation. Transplant Proc 29: 467-468, 1997.
9. Azoulay D, Samuel D, Castaing D, et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg 189: 584-593, 1999.
10. Matsunami H, Makuuchi M, Kawasaki S, et al. A case of familial amyloid polyneuropathy treated with partial liver transplantation using a graft from a living related donor. Transplantation 15: 301-303, 1995.
11. Ikeda S, Takei Y, Yanagisawa N, et al. Partial liver transplantation from living donors in familial amyloid polyneuropathy. Amyloid 4: 18-23, 1997.
12. Coutinho P, Salva M, Lima JL, Barbosa AR. Forty years of experience with type I amyloid neuropathy: review of 483 cases. in: Glenner GG, Costa PP, de Freitas AF, Eds. Amyloid and Amyloidosis. Excerpta Medica, Amsterdam, 1980: 88-98.
13. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 47: 944-951, 1996.
14. Kobayashi S, Morita H, Asawa T, et al. Peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation. Amyloid 10: 17-24, 2003.
15. Herlenius G, Wilczek HE, Larsson M, Ericzon BG. Familial Amyloidotic Polyneuropathy World Transplant Registry. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 77: 64-71, 2004.
16. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 58: 1001-1007, 2002.
17. Kawasaki S, Hashikura Y, Ikegami T, et al. First, case of cadaveric liver transplantation in Japan. J Hepatobiliary Pancreat Surg 6: 387-390, 1999.
18. Takei Y, Ikeda S, Hashikura Y, Ikegami T, Kawasaki S. Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients. Ann Intern Med 131: 592-595, 1999.
19. Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123: 1495-1504, 2000.
20. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 235: 479-485, 1994.
21. Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transplant 8: 787-794, 2002.
22. Yazaki M, Tokuda T, Nakamura A, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 274: 702-706, 2000.
23. Ikeda S. Cardiac amyloidosis: heterogenous pathogenic backgrounds. Intern Med 43: 1107-1114, 2004.
24. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 64: 74-80, 1997.
25. Pomfret EA, Lewis WD, Jenkins RL, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 65: 918-925, 1998.
26. Stangou AJ, Hawkins PN, Heaton ND, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 66: 229-233, 1998.
27. Olofsson B-O, Backman C, Karp K, Suhr OB. Progression of cardiopathy after liver transplantation in patients with familial amyloid polyneuropathy, Portuguese type. Transplantation 73: 745-751, 2002.
28. Westermark P, Sletten K, Johansson B, Cornwell GG III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87: 2843-2845, 1990.
29. Stangou AJ, Hawkins PN. Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol 17: 615-620, 2004.
30. Tashima K, Ando Y, Terazaki H, et al. Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci 171: 19-23, 1999.
31. Sousa MM, Ferrao J, Fernandes R, et al. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. Lab Invest 84: 865-873, 2004.
32. Jonsén E, Suhr O, Athlin E, Wikstöm L. Quality of life after liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid 3: 124-129, 1996.
33. de Carvalho M, Conceicao I, Bentes C, Luis ML. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid 9: 126-133, 2002.
34. Jonsén E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid 8: 52-57, 2001.
35. Haraoka K, Ando Y, Ando E, et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid 9: 247-251, 2002.
36. Ando Y, Tanaka Y, Nakazato M, et al. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem Biophys Res Commun 211: 354-358, 1995.